4-(2-(4-fluorobenzyloxy)ethoxy)-7H-furo[3,2-g]chromen-7-one

ID: ALA3953745

PubChem CID: 11638587

Max Phase: Preclinical

Molecular Formula: C20H16O5

Molecular Weight: 336.34

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  O=c1ccc2c(OCCOCc3ccccc3)c3ccoc3cc2o1

Standard InChI:  InChI=1S/C20H16O5/c21-19-7-6-15-18(25-19)12-17-16(8-9-23-17)20(15)24-11-10-22-13-14-4-2-1-3-5-14/h1-9,12H,10-11,13H2

Standard InChI Key:  PRFBIGZCKZSWSQ-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 25 28  0  0  0  0  0  0  0  0999 V2000
   17.7371   -1.1036    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.7382   -1.9194    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.4464   -2.3256    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.1538   -1.9147    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.4397   -0.6908    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.1464   -1.0932    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.2015   -4.7903    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.1997   -3.1529    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.9084   -3.5582    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.9072   -4.3788    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.6134   -4.7879    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   16.3253   -4.3808    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.3264   -3.5602    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.6157   -3.1466    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.4935   -4.3813    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.4902   -3.5648    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.7126   -3.3156    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.2353   -3.9781    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.7179   -4.6367    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   17.0318   -4.7914    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   14.1971   -2.3357    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   14.9035   -1.9248    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.6125   -2.3311    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.3189   -1.9203    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   17.0279   -2.3266    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  6  1  0
  5  1  1  0
  5  6  2  0
 15  7  1  0
  7 10  2  0
  9  8  2  0
  8 16  1  0
  9 10  1  0
  9 14  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  2  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 15  1  0
 12 20  2  0
  8 21  1  0
 21 22  1  0
 22 23  1  0
 23 24  1  0
 24 25  1  0
 25  2  1  0
M  END

Alternative Forms

Associated Targets(Human)

KCNA1 Tclin Voltage-gated potassium channel subunit Kv1.1 (248 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
KCNA3 Tclin Voltage-gated potassium channel subunit Kv1.3 (1067 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
KCNA5 Tclin Voltage-gated potassium channel subunit Kv1.5 (1353 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 336.34Molecular Weight (Monoisotopic): 336.0998AlogP: 4.13#Rotatable Bonds: 6
Polar Surface Area: 61.81Molecular Species: NEUTRALHBA: 5HBD:
#RO5 Violations: HBA (Lipinski): 5HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: 3.46CX LogD: 3.46
Aromatic Rings: 4Heavy Atoms: 25QED Weighted: 0.39Np Likeness Score: 0.25

References

1.  (2006)  5-phenoxyalkoxypsoralens and methods for selective inhibition of the voltage gated kv1.3 potassium channel, 

Source